Sanofi is laying off 229 employees from its acquired company, Blueprint Medicines. This workforce reduction is part of the integration process following Sanofi's $9.1 billion buyout of Blueprint. The company is also consolidating its office space in Cambridge, Massachusetts. Remaining Blueprint employees will move to Sanofi's Cambridge Crossing campus. These organizational changes aim to align the structure with long-term business priorities.
Cambridge, Massachusetts
https://www.fiercepharma.com/pharma/sanofi-lay-229-blueprint-medicines-staff-close-cambridge-offices-following-acquisition